Crinetics Pharmaceuticals, Inc. (CRNX)

SEC filing

Crinetics Pharmaceuticals, Inc.

CRNX · CIK 1658247

4 · Jan 7, 2026 · Kalofonos Isabel sold 2,500 shares at $55.00/share ($137.5K); exercised options for 2,500 shares

Kalofonos Isabel sold 2,500 shares at $55.00/share ($137.5K); exercised options for 2,500 shares

FORM 4

xslF345X05/wk-form4_1767823884.xmlSEC.gov

Graphics and non-inline formats (not embedded below).